It has been a bumpy ride for the Australian share market lately, but history shows that quality always rises to the top when the dust settles.

And for long-term investors, these market selloffs often present a golden opportunity to snap up some of the ASX's best stocks at more attractive prices.

If you're looking to position your portfolio ahead of a potential rebound, here are three high-quality ASX stocks that analysts are tipping as buys. They are as follows:

CSL Ltd (ASX: CSL)

When it comes to ASX stocks, CSL has long been a favourite among investors — and for good reason.

Despite recent wobbles, CSL remains one of the most consistently profitable businesses on the Australian share market. The biotech giant is best known for its plasma therapies and vaccine division, but it is also making strategic moves in gene therapy and transplant markets through its recent Vifor acquisition.

While short-term headwinds (like plasma collection costs and weak vaccine sales) have weighed on sentiment, many brokers see this as temporary noise. CSL continues to invest in innovation, its margins are expected to recover, and long-term demand for its life-saving therapies remains strong.

It is partly for this reason that Bell Potter rates it as a buy with a $335.00 price target.

Macquarie Group Ltd (ASX: MQG)

Known as the millionaire factory, Macquarie Group is much more than a bank — it is a diversified global financial powerhouse with a strong track record of delivering through the cycle.

Its exposure to infrastructure, green energy, and asset management gives it earnings diversity that few other financials can match. While its market-facing businesses are sensitive to short-term conditions, Macquarie's long-term strategy, strong capital position, and ability to pivot into growth sectors give it serious rebound potential.

Ord Minnett currently has an accumulate rating and $210.00 price target on its shares.

Xero Ltd (ASX: XRO)

Another ASX stock that could be a strong buy is Xero. It is built on incredibly sticky, subscription-based revenue, making it one of the more robust names in the tech sector.

The company's cloud-based accounting platform is used by millions of small businesses globally, and its expansion into adjacent areas like payroll, invoicing, and payments gives it a long runway for growth.

Goldman Sachs estimates that it has a total addressable market (subscribers) of 100 million, this is significantly greater than its current subs of 4 million. As a result, it will come as little surprise to learn that the broker has a buy rating and $201.00 price target on its shares.